Efficacy of Atenativ in Patients With Congenital Antithrombin Deficiency Undergoing Surgery or Delivery
Status:
Not yet recruiting
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
Assess the incidence of the composite of thrombotic events (TEs) and thromboembolic events
(TEEs) in patients with congenital antithrombin deficiency under cover of Atenativ for
surgical procedures or parturition.